Berberis thunbergii var. atropurpurea. DC is one of the popular landscape plants in the USA, but until now lacked report on its chemical composition and biological properties. In this study, the antioxidant and anti-inflammatory activities of the methanolic extract and pure isolates of B. thunbergii var. atropurpurea, Crimson Pygmy, roots were evaluated using established bioassay procedures. The methanolic extract gave an absorbance value of 0.44 at 250 µg/mL concentration in the MTT assay. In addition, the extract inhibited lipid peroxidation (LPO) by 93% and the cyclooxygenase enzymes, COX-1 by 54 and COX-2 by 34%, at 100 µg/mL concentration. Therefore, a bioactivity-guided purification was carried out yielding pure isolates, out of which compounds 3−6 inhibited LPO by 34−66% at 100 µg/mL concentration. Similarly, compounds 1−6 inhibited COX-1 and -2 by 24−65 and 23−43% at 25 µg/mL concentration, respectively. This is the first report of the chemical constituents and biological activities of this plant.
The genus Berberis (Berberidaceae) comprises about 500 species of deciduous and evergreen shrubs throughout the temperate and subtropical regions of the world, which are commonly used in food and medicine. The antioxidant, anti-inflammatory, antibacterial, antifungal, antinociceptive, and antihypertensive activities [1−4] and potential to treat Alzheimer's disease [5] reported for Berberis species were primarily attributed to its alkaloid content. Phytochemical studies have led to the isolation of a number of isoquinoline alkaloids [1, 6, 7] . Among these, berberine was the main isolate from most plants of this genus. This has been used in Indian and Chinese medicines to treat fungal, bacterial, parasite and ocular trachoma infections [8, 9] . Recently, a series of phenolic compounds and triterpenoids have been reported, some of which also showed very good antioxidant and cytotoxic activities [10−13] .
B. thunbergii, Japanese barberry, Crimson Pygmy, native to Japan, has become one of the most popular ornamental plants in the US. Most B. thunbergii plants sold today are the botanical variety atropurpurea DC. with purple foliage. Although B. thunbergii has been studied extensively [2, 14, 15] , there are no reports on the chemistry and bioactivity of B. thunbergii var. atropurpurea. In this study, antioxidant and anti-inflammatory activities of the methanolic extract and its isolates were investigated using MTT [3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide] [16] , lipid peroxidation (LPO) [17] , cyclooxygenase enzymes COX-1 and -2 [17] inhibitory assays.
The methanolic extract (ME) showed good antioxidant and moderate antiinflammatory activities as evidenced by the MTT assay absorbance value of 0.44 at 570 nm at 250 µg/mL concentration, and the LPO, COX-1 and COX-2 assays inhibition values of 93, 54 and 34% at 100 µg/mL concentration, respectively. Therefore, a bioactivity-guided purification of the extract was carried out and afforded berberine (1), jatrorrhizine (2), The pure isolates were also tested for antioxidant activity. The MTT assay results of compounds 1−6 showed absorbance values of 0.075, 0.109, 0.080, 0.088, 0.120 and 0.193 at 570 nm, respectively, at 100 µg/mL concentration. The results showed that the extract had better activity than the pure compounds when compared with vitamin C and TBHQ at 25 µg/mL concentration, which could be explained as either synergism or an additive effect of compounds present in the extract. Ferulates and β-sitosterol were not assayed since their activities are known. The LPO inhibition allowed us to evaluate the radical scavenging capacity of test samples.
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Compounds 1 and 2 did not show LPO inhibition because their UV absorbance [18] interfered with the absorption and emission wavelengths at 350 and 384 nm used in this assay [17] . Compound 3 showed the strongest LPO inhibition by 65%, and 4−6 in the range of 34−50% at 100 µg/mL concentration ( Figure 2 ). The anti-inflammatory activity was tested by measuring the COX-1 and COX-2 enzyme inhibition for the extract and isolates [17] . At 25 µg/mL concentration, compounds 1−6 inhibited COX-1 enzyme by 52, 55, 48, 64, 40 and 29% and COX-2 by 25, 30, 38, 24, 36 and 29%, respectively ( Figure 3 ). Compounds 1−4 showed COX-1 enzyme inhibition, similar to that of aspirin and ibuprofen, which were used in this assay as positive controls. Also, all compounds tested showed lower COX-2 enzyme inhibition compared with COX-1. Interestingly, compound 4 showed COX-1 and COX-2 enzyme inhibitory activity profiles similar to those of aspirin. especially berberine, were still the major components of this plant, except for the sugars. This is the first report of the chemical composition and biological activities of this plant. This is also the first report of MTT antioxidant activity for compounds 1−6, and LPO, COX-1 and COX-2 bioactivities for compounds 3−6. The antioxidant and anti-inflammatory activities exhibited by the extract and isolates support the notion that Crimson Pigmy also contains health beneficial compounds similar to its counterparts in this genus, as well as being a natural source for berberine.
Experimental
General experimental procedures: All solvents used for isolation and purification were of ACS reagent grade (Sigma-Aldrich Chemical Company (St. Louis, MO, USA). NMR spectra were recorded on 500 (Varian Unity ± 500, 1 H NMR) and 125 (Varian Unity ± 500, 13 1 and 1:1) to yield fractions I, 500 mg, and II, 792 mg. Fraction II showed a similar TLC profile as that of the compounds in the water-soluble portion of the extract. Fraction I was subjected to silica gel CC eluted with CHCl 3 -MeOH (10:1), and then by preparative TLC to afford β-sitosterol (27 mg), β-sitosteryl-3-O-β-glucoside (20 mg) and compounds 4 (6 mg), 5 (7 mg) and 6 (6 mg).
Bioactive compounds from Berberis thunbergii var. atropurpurea Natural Product Communications Vol. 8 (2) 2013 167 Compound 1 Yellow powder. 1 H-and 13 C-NMR spectral data identical to those of berberine [18] .
Compound 2
Yellow powder. 1 H-NMR spectral data identical to those of jatrorrhizine [19] .
Compound 3.
Amorphous powder. 1 H-NMR spectral data identical to those of linusitamarin [20] .
Compound 4
Colorless oil. 1 H-and 13 C-NMR spectral data identical to those of β-sitosteryl-3βglucopyranoside-6′-O-palmitate [21] . MTT antioxidant assay: MTT assay was performed according to our previous report [16] . Stock solutions of test extract, compounds and positive controls (Vitamin C and TBHQ) were prepared in DMSO (2 mg/mL for extracts, 0.8 mg/mL for pure compounds, and 0.2 mg/mL for controls). An aliquot of 50 μL of test samples, 150 μL of MTT water solution (1 mg/mL) and 200 μL of DMSO were vortexed in a capped glass vial (2 mL) for 1 min, which was then incubated at 37°C for 24 h. An aliquot (200 μL) of the reaction mixture was pipetted to a 96-well cell culture plate, and the absorbance was tested at 570 nm in duplicate on a Bio-Tek Elx800 universal microplate reader (Bio-Tek Instruments, Inc., Winooski, VT).
Lipid peroxidation inhibitory assay:
The extract (100 μg/mL), compounds (100 μg/mL) and positive controls (BHA, BHT and TBHQ at 10 μM) were tested for LPO inhibitory activities by using fluorescence spectroscopy on a Turner model 450 Fluorometer (Barnstead/Thermolyne Corporation, Dubuque, IA) according to the reported procedure [17] . The liposome, unilamellar vesicles (ULV), was prepared according to the published procedure [17] . The peroxidation was initiated by the addition of 20 μL of FeCl 2 ·4H 2 O (0.5 mM) to the assay mixture [HEPES (100 μL), 1 M NaCl (200 μL), N 2 -sparged Millipore water (1.64 mL), DMSO or test sample (20 μL)] and 20 μL of liposome suspension. The fluorescence was monitored at 0, 1, 3 and every 3 min thereafter up to 21 min. The decrease in fluorescence intensity over time (21 min) indicated the rate of peroxidation. Each sample was assayed in duplicate, and the percent inhibition was calculated with respect to DMSO control.
COX-1 and -2 enzyme inhibitory assay:
The COX-1 and -2 enzyme (prepared from ram seminal vesicles and insect cells cloned with human COX-2 enzyme, respectively, in our laboratory) inhibitory effects of test samples were measured by monitoring the initial rate of O 2 uptake using an Instech micro oxygen chamber and electrode (Instech Laboratories, Plymouth Meeting, PA) attached to a YSI model 5300 biological oxygen monitor (Yellow Springs Instrument, Inc., Yellow Springs, OH) at 37ºC following the published procedure [17] . The test samples (6 μL) were initially added to the chamber full of assay buffer (Tris-1 mM phenol buffer, 600 μL, pH = 7) and hemoglobin (17 μg). COX-1 or COX-2 enzyme (20 μL) was then added and incubated for 2 min. Arachidonic acid (10 μL of solution at 1 mg/mL) was added to initiate the reaction. The data were recorded using QuickLog for windows data acquisition and control software (Strawberry Tree Inc., Sunnyvale, CA). The extract and compounds were tested at 100 and 25 µg/mL concentrations, respectively. The positive controls, commercial Aspirin, Celebrex, Naproxen, and Ibuprofen were tested at 108, 1, 15 and 12 µg/mL, respectively. Each sample was tested in duplicate, and the percent inhibition calculated with respect to DMSO control. The varying concentration of controls used was to achieve the inhibition of enzymes between 50 and 100%.
